These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23274017)

  • 21. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.
    De Luca G; Gibson M; Cutlip D; Huber K; Dudek D; Bellandi F; Noc M; Maioli M; Zorman S; Zeymer U; Secco GG; Mesquita Gabriel H; Emre A; Arntz HR; Rakowski T; Gyongyosi M; Hof AW;
    Arch Cardiovasc Dis; 2013 Mar; 106(3):155-61. PubMed ID: 23582677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention.
    Kasai T; Miyauchi K; Kurata T; Okazaki S; Kajimoto K; Kubota N; Daida H
    Hypertens Res; 2008 Feb; 31(2):235-41. PubMed ID: 18360042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data.
    Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Chung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Circ Cardiovasc Interv; 2012 Aug; 5(4):467-75. PubMed ID: 22872052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of diabetes mellitus on in-hospital and long-term outcomes after heart valve operations.
    Halkos ME; Kilgo P; Lattouf OM; Puskas JD; Cooper WA; Guyton RA; Thourani VH
    Ann Thorac Surg; 2010 Jul; 90(1):124-30. PubMed ID: 20609762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction.
    Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Jeong DS; Sung K; Kim WS; Lee YT; Gwon HC
    Am J Cardiol; 2013 Sep; 112(5):623-9. PubMed ID: 23711811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents.
    Yu X; Chen F; He J; Gao Y; Wu C; Luo Y; Zhang X; Zhang Y; Ren X; Lv S
    Coron Artery Dis; 2013 May; 24(3):217-23. PubMed ID: 23425771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of diabetes mellitus and hypertension for mid-term outcome of patients with acute myocardial infarction who underwent percutaneous coronary intervention.
    Lee MG; Jeong MH; Lee KH; Park KH; Sim DS; Yoon HJ; Yoon NS; Kim KH; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2012 Oct; 60(4):257-63. PubMed ID: 22819036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical revascularization is associated with improved long-term outcomes compared with percutaneous stenting in most subgroups of patients with multivessel coronary artery disease: results from the Intermountain Heart Registry.
    Bair TL; Muhlestein JB; May HT; Meredith KG; Horne BD; Pearson RR; Li Q; Jensen KR; Anderson JL; Lappé DL
    Circulation; 2007 Sep; 116(11 Suppl):I226-31. PubMed ID: 17846308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous coronary intervention in patients with previous coronary artery bypass grafting (from the j-Cypher Registry).
    Yamaji K; Kimura T; Morimoto T; Nakagawa Y; Inoue K; Nobuyoshi M; Mitsudo K;
    Am J Cardiol; 2013 Oct; 112(8):1110-9. PubMed ID: 23827399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.
    Argulian E; Patel AD; Abramson JL; Kulkarni A; Champney K; Palmer S; Weintraub W; Wenger NK; Vaccarino V
    Am J Cardiol; 2006 Jul; 98(1):48-53. PubMed ID: 16784919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.
    Sardi GL; Laynez-Carnicero A; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Catheter Cardiovasc Interv; 2013 May; 81(6):949-56. PubMed ID: 22888029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of individual operator performance using a risk-adjustment model for percutaneous coronary interventions.
    Gössl M; Rihal CS; Lennon RJ; Singh M
    Mayo Clin Proc; 2013 Nov; 88(11):1250-8. PubMed ID: 24182704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus does not increase the risk of adverse long-term outcomes after intracranial stent placement.
    Li BH; Yin YW; Gao CY; Hu ZC; Wang JH; Zhang LL; Li JC
    Cell Biochem Biophys; 2015 Jan; 71(1):413-8. PubMed ID: 25182003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk scores for 30-day mortality after percutaneous coronary intervention: new insights into causes and risk of death.
    Singh M; Lennon RJ; Gulati R; Holmes DR
    Mayo Clin Proc; 2014 May; 89(5):631-7. PubMed ID: 24797644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of metabolic syndrome and diabetes mellitus on cardiovascular events in coronary artery disease without ischemia on stress thallium-201 single photon emission computed tomography after percutaneous coronary intervention].
    Mori T; Ohashi Y; Ejiri J; Takatsuki K; Ichikawa S; Awano K
    J Cardiol; 2005 Sep; 46(3):89-96. PubMed ID: 16218426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience.
    Singh M; Rihal CS; Gersh BJ; Roger VL; Bell MR; Lennon RJ; Lerman A; Holmes DR
    J Am Coll Cardiol; 2008 Jun; 51(24):2313-20. PubMed ID: 18549915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of diabetes on >10-year outcomes after percutaneous coronary intervention.
    Kasai T; Miyauchi K; Kajimoto K; Kubota N; Kurata T; Daida H
    Heart Vessels; 2008 May; 23(3):149-54. PubMed ID: 18484156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.